Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL688P (RNA, 7SL, cytoplasmic 688, pseudogene) is a **pseudogene** derived from the 7SL RNA gene. The 7SL RNA is a crucial non-coding RNA forming the core scaffold of the signal recognition particle (SRP), a ribonucleoprotein complex essential for targeting nascent secretory and membrane proteins to the endoplasmic reticulum during translation[1][3]. In the human genome, there are hundreds of 7SL RNA-derived sequences; the vast majority are **pseudogenes** like RN7SL688P, which are truncated, non-functional copies resulting from retrotransposition or other genomic events[4][5][6]. Unlike functional 7SL RNA, pseudogenes such as RN7SL688P are not believed to produce an active RNA and do not participate directly in SRP function or known biological pathways. There is no evidence that RN7SL688P acts as a therapeutic target, participates in signaling, or has roles in disease or drug interaction. **Note:** - This entry is not a receptor, enzyme, transporter, or recognized therapeutic target. - It is a non-coding RNA pseudogene, and typically, such genomic elements are not directly targeted in therapy, though rare exceptions among pseudogenes can exist when they acquire regulatory functions[2]. No such evidence is present for RN7SL688P. - The entry is technically correct as a pseudogene designation, but it is *not* a canonical therapeutic target as usually defined in drug discovery or cell signaling biology[4][5][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 7SL RNA pseudogene 688 (RN7SL688P).